These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36758379)

  • 1. Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy.
    Mattiola I; Diefenbach A
    Semin Immunol; 2023 Mar; 66():101724. PubMed ID: 36758379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the microbiome on cancer progression and response to anti-cancer therapies.
    Buchta Rosean C; Feng TY; Azar FN; Rutkowski MR
    Adv Cancer Res; 2019; 143():255-294. PubMed ID: 31202360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cancer immunotherapy efficacy by gut microbiota.
    Huo S; Liu L; Liu J; Li Q; Wang J
    Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbes and Cancer.
    Dzutsev A; Badger JH; Perez-Chanona E; Roy S; Salcedo R; Smith CK; Trinchieri G
    Annu Rev Immunol; 2017 Apr; 35():199-228. PubMed ID: 28142322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy.
    Park JS; Gazzaniga FS; Kasper DL; Sharpe AH
    Exp Mol Med; 2023 Sep; 55(9):1913-1921. PubMed ID: 37696895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of microbiota in response to cancer immunotherapy.
    Inamura K
    Semin Cancer Biol; 2020 Oct; 65():164-175. PubMed ID: 31911189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune recognition of cancer.
    Woo SR; Corrales L; Gajewski TF
    Annu Rev Immunol; 2015; 33():445-74. PubMed ID: 25622193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the commensal microbiota on distal tumor-promoting inflammation.
    Buchta Rosean CM; Rutkowski MR
    Semin Immunol; 2017 Aug; 32():62-73. PubMed ID: 28687194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes Function in Tumor Immune Microenvironment.
    Huang Y; Liu K; Li Q; Yao Y; Wang Y
    Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeostatic Immunity and the Microbiota.
    Belkaid Y; Harrison OJ
    Immunity; 2017 Apr; 46(4):562-576. PubMed ID: 28423337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intratumoral microbiota: a new horizon in cancer immunology.
    Liu W; Li Y; Wu P; Guo X; Xu Y; Jin L; Zhao D
    Front Cell Infect Microbiol; 2024; 14():1409464. PubMed ID: 39135638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the microbiota and innate and innate-like lymphocytes.
    Constantinides MG
    J Leukoc Biol; 2018 Mar; 103(3):409-419. PubMed ID: 29345366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy.
    Ginefra P; Lorusso G; Vannini N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Immunity: Lessons From Infectious Diseases.
    Trinchieri G
    J Infect Dis; 2015 Jul; 212 Suppl 1(Suppl 1):S67-73. PubMed ID: 26116736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome in cancer progression and therapy.
    Andreeva NV; Gabbasova RR; Grivennikov SI
    Curr Opin Microbiol; 2020 Aug; 56():118-126. PubMed ID: 33147555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiome in anti-cancer therapy.
    Bashiardes S; Tuganbaev T; Federici S; Elinav E
    Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting innate sensing in the tumor microenvironment to improve immunotherapy.
    Liu Z; Han C; Fu YX
    Cell Mol Immunol; 2020 Jan; 17(1):13-26. PubMed ID: 31844141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.